Episode 93: Stem Cells Are In the News & A Research Update from Dr. Karen Lee, V.P. of Research at the MS Society of Canada

Stem Cells are in the news, and we're talking about the U.S. District Court decision that will impact hundreds of stem cell clinics in the United States and the FDA's ability to regulate them. We'll also share two breakthroughs in stem cell research that will likely impact the future of stem cell therapy.     My guest on the podcast is Dr. Karen Lee, the Vice-President of Research at the MS Society of Canada. Canada has one of the highest rates of MS in the world, and the MS Society of Canada has responded by launching research initiatives on several fronts. Dr. Lee is going to give us an update on some of the research that the MS Society of Canada is involved in, including a major multi-year study that's focused on answering the questions, how and why does MS progress? We have a lot to talk about. Are you ready for RealTalk MS??! ___________   FDA Wins in Federal Court Against For-Profit Stem Cell Clinic Operator  2:15 Harvard Research Team Shows That Stem Cells Can Be Genetically Edited In The Body  7:38 University of California Irvine Uses Nanotech Treatment From Stem Cells to Reverse MS in Mice   10:11 AxoSim Licenses Mini-Brain Technology Developed at Johns Hopkins  12:26 My Interview with Dr. Karen Lee  15:09 Join the RealTalk MS Conversation  26:09 ___________ ADD YOUR VOICE TO THE CONVERSATION I've always thought about the RealTalk MS podcast as a conversation. And this is your opportunity to join the conversation by sharing your feedback, questions, and suggestions for topics that we can discuss in future podcast episodes. Please shoot me an email or call the RealTalk MS Listener Hotline and share your thoughts! Email: [email protected]: (310) 526-2283 ___________ LINKS If your podcast app doesn't allow you to click on these links, you'll find them in the show notes in the RealTalk MS app or at www.RealTalkMS.com FDA Announces Federal Court Decision Against US Stem Cell Clinics In Situ Modification of Tissue Stem and Progenitor Cell Genomes Stem Cell-Derived Exomes as Nanotherapeutics for Autoimmune and Neurodegenerative Disorders CanProCo Study Information & Registration Download the RealTalk MS App for iOS Download the RealTalk MS App for Android Give RealTalk MS a Rating & Review  ___________ Follow RealTalk MS on Twitter, @RealTalkMS_jon, and subscribe to our newsletter at our website, RealTalkMS.com. RealTalk MS Episode 93 Hosted By: Jon Strum Guest: Dr. Karen Lee Tags: MS, MultipleSclerosis, MSResearch, MSSocietyCanada, Stemcells, RealTalkMS